[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioventus Inc Cl A (BVS)

Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 804,109
  • Shares Outstanding, K 83,155
  • Annual Sales, $ 568,090 K
  • Annual Income, $ 22,730 K
  • EBIT $ 62 M
  • EBITDA $ 109 M
  • 60-Month Beta 0.70
  • Price/Sales 1.46
  • Price/Cash Flow 7.81
  • Price/Book 3.61

Options Overview Details

View History
  • Implied Volatility 117.97% (+6.42%)
  • Historical Volatility 44.15%
  • IV Percentile 61%
  • IV Rank 31.31%
  • IV High 308.26% on 11/19/25
  • IV Low 31.23% on 09/04/25
  • Expected Move (DTE 15) 1.78 (18.02%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 142
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 3,744
  • Open Int (30-Day) 3,559
  • Expected Range 8.08 to 11.64

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.09
  • Number of Estimates 2
  • High Estimate $0.09
  • Low Estimate $0.08
  • Prior Year $0.08
  • Growth Rate Est. (year over year) +12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.64 +14.24%
on 03/31/26
10.76 -8.27%
on 04/17/26
+0.91 (+10.16%)
since 03/30/26
3-Month
7.78 +26.86%
on 02/11/26
10.76 -8.27%
on 04/17/26
+1.94 (+24.46%)
since 01/30/26
52-Week
5.81 +69.88%
on 08/05/25
10.76 -8.27%
on 04/17/26
+2.56 (+35.02%)
since 04/30/25

Most Recent Stories

More News
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

MALVERN, Pa., April 30, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today...

AXGN : 43.20 (+3.42%)
TELA : 0.8748 (+1.72%)
ANIK : 12.45 (+0.48%)
MDXG : 3.36 (+8.91%)
ELUT : 1.0200 (+2.00%)
BVS : 9.87 (+2.07%)
Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026

DURHAM, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will...

BVS : 9.87 (+2.07%)
Bioventus: Q4 Earnings Snapshot

Bioventus: Q4 Earnings Snapshot

BVS : 9.87 (+2.07%)
Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results

Q4 reported revenue of $157.9 million increased 2.8% and organic* revenue increased 10.0% Fourth quarter GAAP earnings of $0.21 per diluted share compared to $0.00 in the prior-year period Non-GAAP...

BVS : 9.87 (+2.07%)
Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026

DURHAM, N.C., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”) , a global leader in innovations for active healing, today announced that it will...

BVS : 9.87 (+2.07%)
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference

DURHAM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Chief Executive Officer, will present...

BVS : 9.87 (+2.07%)
HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

BVS : 9.87 (+2.07%)
Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference

DURHAM, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Bioventus President and Chief Executive...

BVS : 9.87 (+2.07%)
Bioventus: Q3 Earnings Snapshot

Bioventus: Q3 Earnings Snapshot

BVS : 9.87 (+2.07%)
Bioventus Reports Third Quarter Financial Results

Q3 reported revenue of $138.7 million was comparable to last year and organic* revenue advanced 8% Third quarter GAAP earnings of $0.05 per diluted share increased compared to the prior-year...

BVS : 9.87 (+2.07%)

Business Summary

Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.

See More

Key Turning Points

3rd Resistance Point 10.22
2nd Resistance Point 10.04
1st Resistance Point 9.96
Last Price 9.87
1st Support Level 9.70
2nd Support Level 9.52
3rd Support Level 9.44

See More

52-Week High 10.76
Last Price 9.87
Fibonacci 61.8% 8.87
Fibonacci 50% 8.28
Fibonacci 38.2% 7.70
52-Week Low 5.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.